| Identification | |
| Name: | 4-Pyridine-2,3,5,6-d4-carboxylicacid, hydrazide (9CI) |
| Synonyms: | Isoniazid-D4;4-Pyridine-2,3,5,6-d4-carboxylic Acid Hydrazide;FSR-3-d;Isonicotinylhydrazine-d4;RP-5015-d4;Tubazid-d4;(4-Pyridine-2,3,5,6-D-carboxylic Acid Hydrazide;FSR-3-d3 |
| CAS: | 774596-24-6 |
| Molecular Formula: | C6H3 D4 N3 O |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)/i1D,2D,3D,4D |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 171.40C |
| Density: | 1.281g/cm3 |
| Refractive index: | 1.584 |
| Specification: | Crystalline Solid usageEng:Labelled Isoniazid. Antibiotic for treatment of Mycobacterium tuberculosis, inhibits mycolic acid biosynthesis. Metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. Selectively induces expression of CYP2E |
| Storage Temperature: | Refrigerator |
| Usage: | Antibacterial (tuberculostatic) |
| Safety Data | |
 |
|
